6533b837fe1ef96bd12a29e5
RESEARCH PRODUCT
Atherosclerosis and Cerebral Ischemic Attacks: Intakes of Cerebrography With Xenon133 Inhaled and Platelet Tests in the Diagnosis, Clinical and Therapeutic Monitoring; The Preventive Role of Dipyridamole
Michel KahnJ. CarlierM. CloarecJean-pierre DelwicheJosé FenollarH. SolvayPaul Selossesubject
AdultMalemedicine.medical_specialtyPlatelet AggregationArteriosclerosismedicine.medical_treatmentVasodilation030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansPlatelet030212 general & internal medicineAgedAerosolsChemotherapyTherapeutic regimenbusiness.industryDipyridamoleArteriosclerosisMiddle Agedmedicine.diseaseSurgeryTherapeutic monitoringDipyridamoleIschemic Attack TransientCardiovascular agentCardiologyFemaleCardiology and Cardiovascular MedicinebusinessXenon Radioisotopesmedicine.drugdescription
A study of patients to develop the significance of the role of the blood plate lets in the recurrence of transient cerebral ischemic attacks in patients with cerebral atheromatous, develop the effectiveness of dipyridamole in the prophy lactic therapeutic regimen. In the group treated with dipyridamole, a 76.3% clinical improvement was recorded (mean increases of 11.2 ml/min. and 11.4 ml/min. of the cerebral hemispheric flows), 15.8% of cases stabilized (mean increases of 1.7 ml/min. and 1.2 ml/min.) and 7.9% failures (mean decreases of 10.4 ml/min. and 14.3 ml/min.) of these same flows. The cerebrography with xenon 133 inhaled as well as the platelet tests used, constitute unfailing means of diagnosing and monitoring the clinical development.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 1984-11-01 | Angiology |